Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in the medically ill: management considerations

D L Evans1, J Staab, H Ward

  • 1Department of Psychiatry, University of Florida College of Medicine, Gainesville 32610, USA.

Depression and Anxiety
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of the alliance on social recovery outcomes and usage in a moderated online social therapy for first-episode psychosis.

Psychology and psychotherapy·2024
Same author

Initial management of blunt and penetrating neck trauma.

BJA education·2021
Same author

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Schizophrenia research·2020
Same author

Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis.

Development and psychopathology·2020
Same author

Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis.

Behavioural and cognitive psychotherapy·2019
Same author

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.

Schizophrenia research·2019
Same journal

Longitudinal Associations Between Anxiety and Depression in Transition From Childhood to Adolescence.

Depression and anxiety·2026
Same journal

Mental Health Status and Healthcare Utilization Inequity Among People Living With HIV: A Cross-Sectional Study Using Inverse Probability Treatment Weighting.

Depression and anxiety·2026
Same journal

Age Differences in Factors Associated With Insomnia Severity: A Comparative Study of Questionnaire Scores and Heart Rate Variability Parameters.

Depression and anxiety·2026
Same journal

Association Between Unmet Educational Aspirations and Depressive Symptoms in Working Young Adults.

Depression and anxiety·2026
Same journal

Depression and Artificial Intelligence Anxiety Among Chinese University Students: A Bayesian Network Analysis.

Depression and anxiety·2026
Same journal

Systematic Review and Exploratory Meta-Analysis of AI-Enabled and Digital Technology-Assisted Interventions for Dental Anxiety During Dental Treatment.

Depression and anxiety·2026
See all related articles

Managing depression in patients with coronary artery disease (CAD), cancer, or HIV is crucial. Antidepressant therapy, particularly SSRIs, can improve outcomes and quality of life while minimizing risks associated with older antidepressants.

Area of Science:

  • Medical management
  • Psychiatry
  • Cardiology
  • Oncology
  • Infectious Diseases

Background:

  • Depression frequently co-occurs with serious medical conditions like coronary artery disease (CAD), cancer, and HIV.
  • Major depression is linked to increased mortality in CAD patients, potentially via reduced heart rate variability.
  • Certain antidepressants carry risks; tricyclic antidepressants (TCAs) may increase sudden death risk and decrease heart rate variability.

Purpose of the Study:

  • To review the management of depression in patients with CAD, cancer, and HIV.
  • To discuss the efficacy and safety of different antidepressant classes in these patient populations.
  • To highlight the role of psychosocial interventions in managing depression in these conditions.

Related Experiment Videos

Main Methods:

  • Literature review of studies on depression management in CAD, cancer, and HIV.
  • Analysis of the impact of depression on mortality and quality of life.
  • Evaluation of antidepressant therapies, including TCAs, SSRIs, and newer agents.
  • Consideration of non-pharmacological interventions like social support and coping skills.

Main Results:

  • Antidepressant therapy is effective for improving quality of life in cancer and HIV patients.
  • SSRIs and newer antidepressants are preferred due to fewer adverse anticholinergic and cardiovascular effects compared to TCAs.
  • Psychosocial interventions can positively influence outcomes in cancer and HIV patients.
  • Depression management in CAD requires careful consideration of cardiac risks associated with certain antidepressants.

Conclusions:

  • Effective management of depression in patients with CAD, cancer, and HIV is essential for improving outcomes.
  • SSRIs and newer agents offer a safer alternative to TCAs for depressed patients with medical comorbidities.
  • Integrating psychosocial support alongside pharmacotherapy can enhance patient well-being and coping mechanisms.